ALITRECUTAN caps moll 10 mg 30 pce

7680688180015 CH-68818 D11AH04 10.04.0.

Reimbursement limitations:

ALITRECUTAN

ALITRECUTAN est indiqué chez l'adulte souffrant d'un eczéma sévère des mains réfractaire à la thérapie, …

ALITRECUTAN caps moll 10 mg 30 pce
ALITRECUTAN caps moll 10 mg 30 pce
ALITRECUTAN caps moll 10 mg 30 pce
1 / 3
google

Details

Product number
6881801
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
alitretinoinum 10 mg, sojae oleum raffinatum 87.148 mg, sojae oleum partim hydrogenatum 5.796 mg, oleum vegetabile hydrogenatum, glyceroli monostearas 40-55, triglycerida media, int-rac-alpha-tocopherolum, Kapselhülle: gelatina, glycerolum, sorbitolum liquidum non cristallisabile corresp. sorbitolum 9.30 mg, titanii dioxidum, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), aqua purificata, pro capsula.

Articles (1)

Alitrecutan 10 mg, Weichkapseln
Weichkapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/09/2023
Patient information leaflet
Français
01/09/2023
Patient information leaflet
Italien
01/09/2023
Professional SmPC
Allemand
01/09/2023
Professional SmPC
Français
01/09/2023
Professional SmPC
Italien
01/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
87.148 MG Substance HBESI
(N/A)
5.796 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
9.3 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 250.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Dermapharm AG

6331 Hünenberg

Authorization information

Swissmedic authorization number
68818
Drug name
Alitrecutan, Weichkapseln
Galenic form
KAPWE
ATC Code
D11AH04
Authorization status
Z
Dispensation category
A
First authorization
19/01/2023
Authorization expiration date
18/01/2028
IT number
10.04.0.
Domain
Human medicine
Field of application
Bei Erwachsenen mit therapierefraktärem schwerem chronischem Handekzem, die eine ausgebaute lokale Behandlung für mind 4 Wochen erhalten und nicht darauf angesprochen haben.

Packaging details

Description (FR)
ALITRECUTAN caps moll 10 mg 30 pce
Description (DE)
ALITRECUTAN Weichkaps 10 mg 30 Stk
Market launch
19/01/2023
Narcotic (BTM)
No

Original drug

Toctino, Weichkapseln
CHF 255.05
View original

Other packaging sizes

ALITRECUTAN caps moll 30 mg 30 pce
30 KAP
View